It wasn’t Starpharma .... it was ENA respiratory unfortunately and they appear to be developing the same thing (obviously not with SPL7013) .... we need to keep the pedal to the metal with this one me thinks ........ lucky SPL7013 is approved for use in other indications so hopefully that sets us apart from these other operators trying to get on the bandwagon as they are only at animal testing stage ....
GLTAH
Early treatment bridge to COVID vax, page-5
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.002(2.04%) |
Mkt cap ! $41.23M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.0¢ | 9.8¢ | $18.37K | 184.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1544 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 90000 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |